Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 3449

1.

Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.

Gehling UM, Ryder JW, Hogan CJ, Hami L, McNiece I, Franklin W, Williams S, Helm K, King J, Shpall EJ.

Exp Hematol. 1997 Oct;25(11):1125-39.

PMID:
9328449
2.
3.

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.

Lemoli RM, Tafuri A, Fortuna A, Petrucci MT, Ricciardi MR, Catani L, Rondelli D, Fogli M, Leopardi G, Ariola C, Tura S.

Blood. 1997 Feb 15;89(4):1189-96.

4.

Ex vivo expansion of CD34+/CD41+ late progenitors from enriched peripheral blood CD34+ cells.

Halle P, Rouzier C, Kanold J, Boiret N, Rapatel C, Mareynat G, Tchirkov A, Berger M, Travade P, Bonhomme J, Deméocq F.

Ann Hematol. 2000 Jan;79(1):13-9.

PMID:
10663616
5.
6.
8.

Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.

Pierelli L, Scambia G, Bonanno G, Coscarella A, De Santis R, Mele A, Battaglia A, Fattorossi A, Romeo V, Menichella G, Mancuso S, Leone G.

Exp Hematol. 1999 Mar;27(3):416-24.

PMID:
10089903
9.

Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.

Briggs M, Adams JA, Brereton ML, Burgess R, Hyde K, Lenehan H, Yin JA.

Br J Haematol. 2001 Dec;115(3):563-8.

PMID:
11736936
10.

Biological characterization of CD34+ cells mobilized into peripheral blood.

Lemoli RM, Tafuri A, Fortuna A, Catani L, Rondelli D, Ratta M, Tura S.

Bone Marrow Transplant. 1998 Dec;22 Suppl 5:S47-50.

PMID:
9989890
11.

Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.

Srour EF, Bregni M, Traycoff CM, Agüero B, Kosak ST, Hoffman R, Siena S, Gianni AM.

Blood Cells Mol Dis. 1996;22(1):68-81.

PMID:
8807087
12.

Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.

Li K, Li CK, Chuen CK, Tsang KS, Fok TF, James AE, Lee SM, Shing MM, Chik KW, Yuen PM.

Eur J Haematol. 2005 Feb;74(2):128-35.

PMID:
15654904
14.
15.
16.

Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6.

Kobari L, Giarratana MC, Poloni A, Firat H, Labopin M, Gorin NC, Douay L.

Bone Marrow Transplant. 1998 Apr;21(8):759-67.

17.

Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin.

Kratz-Albers K, Scheding S, Möhle R, Bühring HJ, Baum CM, Mc Kearn JP, Büchner T, Kanz L, Brugger W.

Exp Hematol. 2000 Mar;28(3):335-46.

PMID:
10720698
19.

Increased expansion and differentiation of cord blood products using a two-step expansion culture.

McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S.

Exp Hematol. 2000 Oct;28(10):1181-6.

PMID:
11027837

Supplemental Content

Support Center